Daniel Z.
- Country
- Poland
- Department
- Neurology
Research Overview
- Open-Label Long-Term Safety and Tolerability of ML-007C-MA (fesoterodine) in Adults with Hallucinations and Delusions of Alzheimer’s Disease Psychosis
- Open-Label Extension Study of Dexamethasone Sodium Phosphate in Patients with Ataxia Telangiectasia Following IEDAT-04-2022 Participation
- Evaluation of Neurological Effects of Dexamethasone Sodium Phosphate Encapsulated in Autologous Erythrocytes in Pediatric Ataxia Telangiectasia: A Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 32 of 55 partner sites.
Specializations
Neurological Disorders
The investigator specializes in the treatment and research of progressive neurological conditions, with particular emphasis on Parkinson's Disease and Ataxia Telangiectasia.
- Movement Disorders
- Tremor Management
- Neurological Symptom Control
Their work encompasses innovative therapeutic approaches for managing motor symptoms and improving patient functionality.
Motor Function Studies
The investigator focuses on evaluating treatments that target functional and performance-based impairments, particularly in relation to tremor control and movement disorders.
- Functional Assessment
- Performance Metrics
- Long-term Symptom Management
Their research aims to improve daily living activities and motor function in patients with neurological conditions.
Pediatric Neurology
The investigator has developed expertise in treating central nervous system symptoms in young patients, particularly focusing on rare genetic disorders affecting movement and coordination.
- Pediatric Movement Disorders
- CNS Symptom Management
- Developmental Neurology
Their work includes specialized assessment of neurological conditions in children aged 6-9 years.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.